Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 May;67(5):1102–1105. doi: 10.1038/bjc.1993.202

A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia.

S Downer 1, S Joel 1, A Allbright 1, H Plant 1, L Stubbs 1, D Talbot 1, M Slevin 1
PMCID: PMC1968469  PMID: 8494706

Abstract

Patients with breast cancer treated with MPA often report an improvement in appetite. Similar appetite stimulation is seen in patients treated with some corticosteroids, but MPA has a potential advantage over these drugs in that it does not exert a catabolic effect. MPA (100 mg tds orally) has therefore been compared with placebo in 60 patients with advanced malignant disease. Twenty-one patients in the MPA group and 20 in the placebo group were receiving chemotherapy. Patients were treated for 6 weeks and were assessed at weeks 0, 3 and 6 for appetite, energy, mood and pain using visual analogue scales. Nutritional status was assessed by the measurement of serum proteins and anthropometrics. Karnofsky score was recorded as a measure of performance status. There was a significant improvement in appetite in the MPA group between weeks 0 (pre-study) and 3 (P = 0.0002) and 0 and 6 (P = 0.015). There was no significant improvement in appetite in the placebo group. Supporting this finding was the significant increase in serum thyroid binding pre-albumin and retinol binding protein in the MPA group between weeks 0 and 3 and 0 and 6 (P = 0.023 and P = 0.039 respectively). These two parameters showed no significant change in the placebo group. There was no change in anthropometric measurements, weight, performance status, energy, mood or pain in either group. These data indicate that there was a significant increase in appetite in anorexic patients with advanced cancer treated with MPA which was reflected in increases in rapid turnover proteins reported to reflect nutritional status. However, this apparent increase in appetite did not result in improved weight, performance status, energy levels, mood or relief of pain. Further studies to investigate the effect of higher doses of MPA are indicated.

Full text

PDF
1102

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aitken R. C. Measurement of feelings using visual analogue scales. Proc R Soc Med. 1969 Oct;62(10):989–993. doi: 10.1177/003591576906201005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bernstein I. L., Sigmundi R. A. Tumor anorexia: a learned food aversion? Science. 1980 Jul 18;209(4454):416–418. doi: 10.1126/science.6930106. [DOI] [PubMed] [Google Scholar]
  3. Carpentier Y. A., Barthel J., Bruyns J. Plasma protein concentration in nutritional assessment. Proc Nutr Soc. 1982 Sep;41(3):405–417. doi: 10.1079/pns19820055. [DOI] [PubMed] [Google Scholar]
  4. Goodinson S. M. Anthropometric assessment of nutritional status. Prof Nurse. 1987 Sep;2(12):388–393. [PubMed] [Google Scholar]
  5. Goodinson S. M. Biochemical assessment of nutritional status. Prof Nurse. 1987 Oct;3(1):8–12. [PubMed] [Google Scholar]
  6. Holmes S., Dickerson J. W. Malignant disease: nutritional implications of disease and treatment. Cancer Metastasis Rev. 1987;6(3):357–381. doi: 10.1007/BF00144270. [DOI] [PubMed] [Google Scholar]
  7. Ingenbleek Y., Van Den Schrieck H. G., De Nayer P., De Visscher M. Albumin, transferrin and the thyroxine-binding prealbumin/retinol-binding protein (TBPA-RBP) complex in assessment of malnutrition. Clin Chim Acta. 1975 Aug 18;63(1):61–67. doi: 10.1016/0009-8981(75)90379-4. [DOI] [PubMed] [Google Scholar]
  8. Muto Y., Smith J. E., Milch P. O., Goodman D. S. Regulation of retinol-binding protein metabolism by vitamin A status in the rat. J Biol Chem. 1972 Apr 25;247(8):2542–2550. [PubMed] [Google Scholar]
  9. Ota D. M., Frasier P., Guevara J., Foulkes M. Plasma proteins as indices of response to nutritional therapy in cancer patients. J Surg Oncol. 1985 Jul;29(3):160–165. doi: 10.1002/jso.2930290306. [DOI] [PubMed] [Google Scholar]
  10. Schag C. C., Heinrich R. L., Ganz P. A. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol. 1984 Mar;2(3):187–193. doi: 10.1200/JCO.1984.2.3.187. [DOI] [PubMed] [Google Scholar]
  11. Thean K., Yo S. L., Nambiar R., Lim P. H., Tan I. K. The use of serum transferrin in the evaluation of protein-calorie malnutrition in cancer patients. Ann Acad Med Singapore. 1988 Jan;17(1):124–128. [PubMed] [Google Scholar]
  12. Weisberg H. F. Evaluation of nutritional status. Ann Clin Lab Sci. 1983 Mar-Apr;13(2):95–106. [PubMed] [Google Scholar]
  13. Wesdorp R. I., Krause R., von Meyenfeldt M. F. Cancer cachexia and its nutritional implications. Br J Surg. 1983 Jun;70(6):352–355. doi: 10.1002/bjs.1800700615. [DOI] [PubMed] [Google Scholar]
  14. Zigmond A. S., Snaith R. P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x. [DOI] [PubMed] [Google Scholar]
  15. de Haes J. C., van Knippenberg F. C., Neijt J. P. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer. 1990 Dec;62(6):1034–1038. doi: 10.1038/bjc.1990.434. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES